OpenCBD Collective

@nftmufettisi @BioProtocol @peptai_ We are at the beginning of DESCI supercycle

DeSci is heating up again @BioProtocol launchpad just flipped the switch on the next Ignition Sale @peptai_ and it’s already 5.9x oversubscribed in under 30 minutes. Here’s everything you need to know before you ape in: 1. No BioXP? You’re still in. You can now enter with a 1:1 model. - Every $1 = treated as 1 BioXP - Deposit $1000 USDC > counted as $1000 + 1000 BioXP No excuses. Everyone gets a seat. 2. BioXP = your real weapon Allocations are NOT equal they’re proportional. You can boost your weight by burning $BIO: - 1 BioXP = $0.01 in $BIO - Burn $100 > get 10,000 BioXP Play: Split capital. - Buy BioXP > increase weight - Deploy USDC > secure allocation 3. Staking is the long game (and short-term alpha) Stake $BIO and double dip: - Earn daily BioXP during the 13-day sale window - Increase your allocation dynamically - Become eligible for airdrops Bonus: - 20% of total supply > reserved for BIO stakers - 5% > distributed via Ignition Sale Max lock (2 years) > up to 8x BioXP emission power 4. Sale mechanics (don’t ignore this): - Raise: $50,000 - FDV: $1,000,000 - Max per wallet: $10,000 - Allocation = proportional to BioXP weight - Oversubscribed? Excess USDC refunded 5. Timing matters - Sale ends: May 14, 13:00 UTC - BioXP keeps accumulating during the entire 13-day window Meaning: Your position isn’t static it evolves. PeptAI is already running autonomous agents that design, validate, and even commission real wet-lab experiments end-to-end. in short More BioXP = more allocation. Stakers win twice. Welcome to the DeSci meta ***This is not an advertisement or paid sponsorship. It is shared for informational purposes only. DYOR will save you

Gmgn. We are going to onboard users from CBD-related forums. If you know some good communitites, feel free to share or dm us.

@YDecurious no doubt

DESCI-tokens spearheading the Bullrun 🔥💪

@BioLLM_ @colosseum Awesome. Keep building!

Here it is! Our week 4 update for the solana @colosseum hackathon! We are so excited to push our innovative peptide / CRISPR product at the 11th hour in this fiercely competitive hackathon! Let's show some love guys!

@VerbinnenAndrew @anagenxyz

only one DeSci project has the infrastructure to legally sell compounded peptides come July @anagenxyz

@zacxbt @TBDeSci @ResearchHub @pumpdotscience #desci szn just started

the $trackedbio thesis is simple - ai can generate infinite drug ideas now - someone has to test them in biology - @tbDeSci builds the tooling - ai + computer vision for research - fruit fly / mouse / lab study automation - connected to @ResearchHub x @pumpdotscience - token launched in nov 2024 - advisors include alex zhavoronkov ceo of insilico medicine ($4.6 billion marketcap) a company focused on ai drug discovery not financial advice (desci szn?)

#DESCI supercycle here.

@BitmanTW we will appreciate if you can check our platform. we need more support.

People panic sold $PEPTIDE and $PEPT at bottom just because their favorite KOLs dumped and nuked the chart yesterday The thesis hasn’t changed lol

@RainsRevenge we will appreciate if you can check our platform. we need more support.

Health maxxing money maxxing knowledge maxxing Life maxxing

@CryptoStacksss we will appreciate if you can check our platform. we need more support.

Aped a bag of $SASHA DeSci philanthropic and bio-protocol play Allows people to fund treatments for rare diseases, serving as a living proof-of-cure mechanism. The initiative is backed by a Harvard/YC alumni founder and is actively incorporating the "Sasha" project under its wing, combining the high-engagement donation meta with the rapidly growing DeSci narrative. It bridges real-world medical breakthroughs with blockchain technology, making it an extremely rare intersection of impact and technical utility. The best part? They have a bio protocol affiliate badge Mcap: 27k CA: BiAQHYo5Y1umMRbuupdoksKuk6pVbQEHs8fJf8UYpump

The CBD industry is growing rapidly, yet it still suffers from a critical problem: Too much marketing hype, too little transparent, high-quality data. Most "evidence" comes from small industry-funded studies or scattered personal stories. Users are left guessing what actually works, at what dose, with which products and cannabinoid profiles. This is exactly why we are building **OpenCBD Collective**. We are creating a decentralized citizen science platform (V1) where real people can anonymously contribute structured self-reports about their CBD experiences - including dose, product type, strain, cannabinoid & terpene profiles, and subjective effects. By going **#DeSci**, we can do what traditional research struggles with: - Collect data at scale from diverse real-world users - Maintain full transparency and open access to the dataset - Let the community design and participate in experiments - Build collective knowledge without gatekeepers **The benefits are significant:** - Better, unbiased understanding of how different cannabinoids actually affect people - Higher industry standards through public data - More informed decisions for millions of users - True community ownership of the knowledge being created OpenCBD Collective is not another CBD brand or review site. It is infrastructure for open, transparent, and community-owned science in the cannabinoid space. We believe the future of wellness research should be decentralized, open, and driven by those who actually use these compounds. Data will be open. Governance will be community-led. Science will move faster. This is just the beginning. Not medical advice. All reports are voluntary and anonymous. What are your thoughts on the current state of cannabinoid research?

@peptidefolio nice, hope to appear there soon. launching platform in an hour.

PeptideFolio is live. The cleanest way to track the Peptide, DeSci, and Biohacking economy across Stocks and Crypto.

@BitmanTW @TBDeSci good job! good list of amazing projects!

My low cap picks for DeSci x Biotech 1. @TBDeSci $trackedbio CA: 7t1T28iMh5GsW8oTMx52x3u3M3hDbaY8psbL3rZ6BMrn It’s the official DeSci token of a real biotech company, Tracked Biotechnologies, focused on AI-driven automated phenotyping across flies, mice, and humans, with real products like TrackedFlyBox and active CRO services already in place. The bullish case comes from a successful ResearchHub replication study (which even got attention from Brian Armstrong), upcoming exposure at SynBioBeta 2026, a 10% revenue buyback mode. 2. @HairDAO_ $LAB CA: 3NVRZqJ43axJ7Jy8qtADxjFzgk8s2o5zaoLfQWRaAh7A It’s the lab token under HairDAO, a Solana-based DeSci project focused on hair regeneration R&D, combining real-world lab research with a decentralized science community. The bullish case comes from HairDAO already pushing forward with patents, tissue experiments, and a tissue bank, giving it real growth potential. It also sits right at the intersection of DeSci and the hair/peptide narrative, backed by actual experimental progress rather than just hype. 3. @BlupillAging $BLUPILL CA: drxLcknZZCeKaj1ABMUh4CeCGxYhB5mGihdGSUHdrug) The DeSci longevity token on @pumpdotscience, focused on using Sildenafil (Viagra) for lifespan research, led by a team of PhD scientists. Strong angle comes from real longevity use cases, scientist backing, and positioning within the DeSci + peptide narrative. Recently finished its initial launch phase, with a $DOCS holder airdrop coming and further experiments ahead. 4. @spark_sciences $SPARK CA: 2RDJ2BifKMPad67H7YfxM3JCVHPsjHeKpJGNwTxXpump A Solana-based DeSci platform focused on decentralized research funding, offering on-chain transparent grants, milestone-based unlocks, and public verification so anyone can fund and support real scientific work. The thesis is strong around its open, cross-disciplinary funding model, combined with on-chain governance and transparency. Recently gaining traction in DeSci discussions, with Realm DAO governance and active community initiatives. Worth watching their Telegram and upcoming grant activity. 5. @desciatoms $DATOMS CA: Hkbek42wiKQmVmGJYqfD6nbM3Lppyia7ZfY9k9ZioBLV A Solana-based DeSci analytics and visualization tool, offering market updates, 24h top gainers, and insights into total market cap and volume across the sector. The thesis is centered around data aggregation and visibility, helping fill the information gap in DeSci and acting as a useful dashboard for both long-term holders and researchers tracking the ecosystem. They’ve been consistently posting market reports and staying active within the DeSci community. Worth following on X for a clear overview of sector trends and emerging projects. 6. @rand_longevity $COQ CA: ozXG55AM1rqZS345kgDc21xCTaZKgzfXRXCF7Gydrug A Solana-based DeSci longevity token centered around CoQ10, a key mitochondrial compound linked to energy production and aging research. The angle is straightforward, it connects to a real supplement with established longevity relevance, fitting well into the broader DeSci + peptide + mitochondrial narrative. Recently showing up in longevity discussions, making it one to watch as DeSci health-related narratives continue to develop.

@JatevoId @GoogleDeepMind great and useful update! keep working

🧬 Big update for bio.jatevo.ai We now visualize structure predictions for almost every known protein — powered by the open AlphaFold Protein Structure Database from @GoogleDeepMind & EMBL-EBI, with confidence-aware 3D rendering. Hope it helps researchers push forward — from drug design to sustainability. $JTVO $BIO

@peptai_ we are entering the phase of new narrative in bioscience. Amazing product!

Introducing PeptAI A fleet of autonomous agents for peptide drug discovery. PeptAI removes the handoffs between discovery, synthesis, and wet-lab validation, the parts that slow most pipelines down. How it works: > Runs a 9-gate pipeline (8 computational gates and 1 wet-lab gate) 24/7 > Publishes every gate decision openly and in real time via @Molecule_sci Labs > Automatically pays from its own wallet for wet-lab experiments (SPR validation via @adaptyvbio) when gate milestones are reached > Learns from wet-lab results and refines candidates across multiple runs The fleet: → Agent-01: GLP-1R, metabolic health: 35 candidates advancing → Agent-02: KISS1R, fertility: 2 of 10 advanced to G9 → Agent-03: OX2R, ADHD: lead candidate ready for wet lab → Agent-04: community-selected target: queued The fleet scales with budget. Each agent runs the same 9-gate pipeline against its receptor, 24/7. There are plenty of AI drug discovery pipelines. Most still have humans deciding which candidates advance. PeptAI's agent makes those calls itself, gate by gate. Candidates have to clear 8 computational gates to earn a wet-lab recommendation. Depending on the gate, the candidate is redesigned or discarded. Every decision is published on-chain. PeptAI runs on a stack of open scientific tools and protocols: > BIOS @bioaidevs: knowledge layer for literature search and novelty checks. When an agent needs to know what's been discovered or what the literature says about a target, it calls BIOS. > Litefold @try_litefold: molecular dynamics for conformational stability across G5 > Adaptyv Bio @adaptyvbio: wet-lab synthesis and SPR validation at G9 > Molecule Labs @Molecule_sci: on-chain publication of every gate decision in real time > @base: x402 infrastructure for machine-to-machine payments What you can do with PeptAI: • Follow along here for gate decisions, candidates, and updates as the pipeline runs • Use the open methodology to benchmark your own pipeline against the gates PeptAI is experimental and actively evolving. Gates, tools, and thresholds change as it learns. Discover PeptAI now: app.bio.xyz/agents/peptai

@BioProtocol Major update. Great job!

The next BioXP upgrade is live. → Ignition Sales now open to anyone with USDC → Mint BioXP instantly by spending BIO → BioXP decides share when sales are oversubscribed Details ↓

Welcome to OpenCBD Collective We are building an open, decentralized platform for citizen science around CBD and cannabinoids. Real and transaprent data with anonymous self-reports. Community-driven experiments. Not a medical advice - only voluntary personal experiences.